{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-120176","form_type":"8-K","ticker":"VSEE","cik":"0001864531","company_name":"VSEE HEALTH, INC.","filed_at":"2024-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.159056+00:00","generated_at":"2026-05-29T23:14:10.928115+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"VSee Health Q3 revenue up 131% to $3.4M; net loss $51.8M on $55M goodwill impairment","bullets":["Q3 2024 revenue $3.4M (up 131% YoY); 9-month revenue $6.6M (+51%).","Net loss $51.8M in Q3 driven by $55M goodwill impairment; pro forma net loss $0.4M ($(0.02)/share).","Cash $2.3M at Sept 30; no guidance provided.","Pro forma 9-month net loss $(0.16)/share vs $(0.24)/share a year ago.","Expanded partnerships with Seven Corners, SkywardRx, Ava Robotics; launched Aimee and GLP-1 telehealth program."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-120176","json":"https://secwatch.observer/filing/0001104659-24-120176.json","markdown":"https://secwatch.observer/filing/0001104659-24-120176.md","text":"https://secwatch.observer/filing/0001104659-24-120176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924120176/0001104659-24-120176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924120176/tm2428698d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:14:10.928115+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}